Financials

News Ideas Technicals Forecast

IMVT fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of Immunovant, Inc.

Total assets of IMVT for Q3 23 is 711.45 M USD, 143.59% more than the previous Q2 23. And total liabilities decreased by 20.26% in Q3 23 to 32.1 M USD.

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—